In the first of what will be a series of hearings on sudden price hikes of off-patent drugs, the Senate’s Special Committee on Aging on Wednesday made no attempt to veil their contempt for Turing Pharmaceuticals and its ilk.
“My biggest challenge today, is to not lose my temper,” Sen. Claire McCaskill (D-Mo.), ranking member of the committee, said in her opening statement. “The facts that are underlying this hearing are so egregious that it is hard not to get emotional about it.”
McCaskill went on to openly mock Martin Shkreli, CEO and founder of Turing, for callously raising prices while spending millions to be the sole owner of a Wu-Tang Clan album. (Later in the hearing, she simply referred to Shkreli as “Mr. Wu-Tang.”)